An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation

Cancer Letters
Bok-Soon LeeChul-Ho Kim

Abstract

The proapoptotic death receptor 4 (DR4), along with DR5, is currently regarded as a promising target for development of agonistic anti-cancer agents due to its tumor-selective apoptosis-inducing ability with no significant cytotoxicity to normal cells. In this study, we examine susceptibility of various head and neck cancer (HNC) cells and mechanism of cell death to an anti-DR4 agonistic monoclonal antibody (mAb), AY4. AY4 as a single agent induced caspase-dependent apoptotic cell death of KB and HN9, but not in SNU899 and FaDu cell lines. AY4 treatment resulted in accumulation of intracellular reactive oxygen species (ROS) generated from mitochondria in AY4-sensitive cells. Blockade of ROS production by N-acetyl-l-cysteine (NAC) resulted in protection of AY4-sensitive cells against AY4-induced apoptosis. ROS generation induced by AY4 treatment triggered down-regulation of anti-apoptotic molecules of Bcl-xL and X-linked inhibitor of apoptosis (XIAP) without affecting the expression levels of DR4, Mcl-1, and survivin. AY4 also inhibited growth of pre-established HN9 tumors in a nude mouse xenograft model and did not show noticeable cytotoxicity in a zebrafish model. Our results provide further insight into the mechanism of DR4-m...Continue Reading

References

Jan 25, 1985·Science·P A Cerutti
Jan 1, 1994·Immunology Today·T M Buttke, P A Sandstrom
May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Nov 14, 1997·Acta Oto-laryngologica·S Y KimT E Carey
Jul 3, 1999·The Journal of Biological Chemistry·Y J Lee, E Shacter
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Dec 28, 1999·BioFactors·V GoossensJ Grooten
Oct 18, 2000·Free Radical Biology & Medicine·E Cadenas, K J Davies
Apr 3, 2001·Nature Medicine·D LawrenceA Ashkenazi
Jan 5, 2002·Physiological Reviews·Wulf Dröge
Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Sep 16, 2004·Molecular and Cellular Biology·M Stacey RicciWafik S El-Deiry
May 14, 2005·CA: a Cancer Journal for Clinicians·Irene M GhobrialAlex A Adjei
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Feb 18, 2006·Cell Death and Differentiation·H J KimA S Baldwin
Sep 23, 2006·The Journal of Pharmacology and Experimental Therapeutics·Jirapan MoungjaroenYon Rojanasakul
Jul 6, 2007·Cancer Biology & Therapy·Xiaoyang RenXiangwei Wu
Sep 11, 2007·Burns : Journal of the International Society for Burn Injuries·Clarabelle PhamGuy Maddern
May 20, 2008·Lancet·Athanassios ArgirisRobert L Ferris
Jun 5, 2008·The Journal of Clinical Investigation·Avi Ashkenazi, Roy S Herbst
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Dec 25, 2009·Apoptosis : an International Journal on Programmed Cell Death·Peter M Eimon, Avi Ashkenazi
May 13, 2010·Proceedings of the National Academy of Sciences of the United States of America·Chang-Han LeeYong-Sung Kim

❮ Previous
Next ❯

Citations

Aug 29, 2013·Annals of Surgical Oncology·Hyun-Young ChaChul-Ho Kim
May 26, 2015·Expert Opinion on Therapeutic Targets·Bora LimWafik S El-Deiry
Nov 3, 2004·Biology of the Cell·Pernette J Verschure
Jun 19, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marije B OverdijkPeter Boross
Jul 13, 2018·BMC Pharmacology & Toxicology·Arthur Cássio de Lima LunaDurvanei Augusto Maria

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.